Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Ding, Xiao ^a   Dai, Honghai ^a,b   Hui, Zhouguang ^a   Ji, Wei ^a   Liang, Jun ^a   Lv, Jima ^a   Zhou, Zongmei ^a   Yin, Weibo ^a   He, Jie ^a   Wang, Luhua ^a  

^a CANCER HOSPITAL   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Brain metastases; Lymph node ratio; Non small cell lung cancer; Non squamous cell cancer; Prophylactic cranial irradiation; Risk factors

Indexed keywords

CISPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN METASTASIS; CANCER INCIDENCE; CANCER PATIENT; CANCER STAGING; DISEASE FREE SURVIVAL; DRUG TREATMENT FAILURE; FEMALE; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; RISK FACTOR; SKULL IRRADIATION;

ADULT; AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84864353377     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-119     Document Type: Article

References (41)

1. Schouten LJ, Rutten J, Huveneers HAM, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002, 94:2698-2705. 10.1002/cncr.10541, 12173339.
2. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, Ginsberg RJ. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995, 109:120-129. 10.1016/S0022-5223(95)70427-2, 7815787.
3. Newman SJ, Hansen HH. Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma. Cancer 1974, 33:492-496. 10.1002/1097-0142(197402)33:2<492::AID-CNCR2820330225>3.0.CO;2-O, 4812766.
4. Sorensen JB, Hansen H, Hansen M, Dombernowsky P. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 1988, 6:1474-1480.
5. Komaki R, Scott CB, Sause WT, Johnson DH, Taylor SG. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Int J Radiat Oncol Biol Phys 1997, 39:537-544. 10.1016/S0360-3016(97)00365-9, 9336129.
6. Cox J, Yesner R. Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. Am Rev Respir Dis 1979, 120:1025-1029.
7. Law A, Karp DD, Dipetrillo T, Daly BT. Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma. Cancer 2001, 92:160-164. 10.1002/1097-0142(20010701)92:1<160::AID-CNCR1304>3.0.CO;2-X, 11443622.
8. Carolan H, Sun AY, Bezjak A, Yi QL, Payne D, Kane G, Waldron J, Leighl N, Feld R, Burkes R. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?. Lung Cancer 2005, 49:109-115. 10.1016/j.lungcan.2004.12.004, 15949596.
9. Chen AM, Jahan TM, Jablons DM, Garcia J, Larson DA. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer. Cancer 2007, 109:1668-1675. 10.1002/cncr.22565, 17342770.
10. Ceresoli GL, Reni M, Chiesa G, CARRETTA A, SCHIPANI S, PASSONI P, BOLOGNESI A, ZANNINI P, VILLA E. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer 2003, 95:605-612.
11. Mamon HJ, Yeap BY, J nne PA, Reblando J, Shrager S, Jaklitsch MT, Mentzer S, Lukanich JM, Sugarbaker DJ, Baldini EH. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol 2005, 23:1530-1537. 10.1200/JCO.2005.04.123, 15735128.
12. 1ben G, St blen F, Wilhelm H, Menker H, Teschler H. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol 1999, 17:2700-2709.
13. Wang S, Ye X, Ou W, Lin Y, Zhang B, Yang H. Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer. Lung Cancer 2009, 64:238-243. 10.1016/j.lungcan.2008.08.012, 18838190.
14. Andre F, Grunenwald D, Pujol J, Girard P, Dujon A, Brouchet L, Brichon P, Westeel V, Le Chevalier T. Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy. Cancer 2001, 91:2394-2400. 10.1002/1097-0142(20010615)91:12<2394::AID-CNCR1273>3.0.CO;2-6, 11413530.
15. Cox JD, Scott CB, Byhardt RW, Emami B, Russell AH, Fu KK, Parliament MB, Komaki R, Gaspar LEW. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung: analysis of radiation therapy oncology group trials. Int J Radiat Oncol Biol Phys 1999, 43:505-509. 10.1016/S0360-3016(98)00429-5, 10078629.
16. Komaki R, Scott CB, Byhardt R, Emami B, Asbell SO, Russell AH, Roach M, Parliament MB, Gaspar LE. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1998, 42:263-267.
17. Cox JD, Stanley K, Petrovich Z, Paig C, Yesner R. Cranial irradiation in cancer of the lung of all cell types. JAMA 1981, 245:469-472. 10.1001/jama.1981.03310300023013, 7452872.
18. Russell A, Pajak T, Selim H, Paradelo J, Murray K, Bansal P, Cooper J, Silverman S, Clement J. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1991, 21:637-643. 10.1016/0360-3016(91)90681-S, 1651304.
19. Umsawasdi T, Valdivieso M, Chen TT, Barkley HT, Booser DJ, Chiuten DF, Dhingra HM, Murphy WK, Dixon CL, Farha P. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol 1984, 2:253-259.
20. Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: Primary analysis of Radiation Therapy Oncology Group Study RTOG 0214. J Clin Oncol 2011, 29:272-278. 10.1200/JCO.2010.29.1609, 3056462, 21135270.
21. Greene FL. AJCC cancer staging manual 2002, Springer, New York.
22. Robnett TJ, Machtay M, Stevenson JP, Algazy KM, Hahn SM. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. J Clin Oncol 2001, 19:1344-1349.
23. Gaspar LE, Chansky K, Albain KS, Vallieres E, Rusch V, Crowley JJ, Livingston RB, Gandara DR. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: A retrospective review by the Southwest Oncology Group. J Clin Oncol 2005, 23:2955-2961. 10.1200/JCO.2005.08.026, 15860851.
24. Topkan E, Parlak C, Kotek A, Yuksel O, Cengiz M, Ozsahin M, Pehlivan B. Impact of Prophylactic Cranial Irradiation Timing on Brain Relapse Rates in Patients with Stage IIIB Non-small-cell Lung Carcinoma Treated with Two Different Chemoradiotherapy Regimens. Int J Radiat Oncol Biol Phys 2012, 83:1264-1271.
25. Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, Perez CA, Hendrickson FR. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980, 6:1-9. 10.1016/0360-3016(80)90195-9, 6154024.
26. Mandell L, Hilaris B, Sullivan M, Sundaresan N, Nori D, Kim JH, Martini N, Fuks Z. The treatment of single brain metastasis from non-oat cell lung carcinoma: Surgery and radiation versus radiation therapy alone. Cancer 1986, 58:641-649.
27. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995, 13:1880-1892.
28. Strauss GM, Herndon J, Sherman D, Mathisen D, Carey R, Choi N, Rege V, Modeas C, Green M. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992, 10:1237-1244.
29. Skarin A, Jochelson M, Sheldon T, Malcolm A, Oliynyk P, Overholt R, Hunt M, Frei E. Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: Long-term follow-up in 41 patients. J Surg Oncol 1989, 40:266-274. 10.1002/jso.2930400413, 2538680.
30. Jacobs RH, Awan A, Bitran JD, Hoffman PC, Little AG, Ferguson MK, Weichselbaum R, Golomb HM. Prophylactic cranial irradiation in adenocarcinoma of the lung a possible role. Cancer 1987, 59:2016-2019. 10.1002/1097-0142(19870615)59:12<2016::AID-CNCR2820591208>3.0.CO;2-4, 3567864.
31. 1ben G, Teschler H, Stamatis G, Wagner H, Passlick B, Petersen V. Prophylactic cranial irradiation in operable stage IIIA non-small-cell lung cancer treated with neoadjuvant chemoradiotherapy: Results from a German multicenter randomized trial. J Clin Oncol 2007, 25:4987-4992. 10.1200/JCO.2007.12.5468, 17971598.
32. Arrieta O, Saavedra-Perez D, Kuri R, Aviles-Salas A, Martinez L, Mendoza-Posada D, Castillo P, Astorga A, Guzman E, De la Garza J. Brain metastasis development and poor survival associated with carcinoembryonic antigen(CEA) level in advanced non-small cell lung cancer: a prospective analysis. BMC cancer 2009, 9:119-127. 10.1186/1471-2407-9-119, 2679041, 19386089.
33. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, Perez©\Tamayo R, Rotman M. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group. Cancer 1987, 59:1874-1881. 10.1002/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z, 3032394.
34. Bajard A, Westeel V, Dubiez A, Jacoulet P, Pernet D, Dalphin J, Depierre A. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer 2004, 45:317-323. 10.1016/j.lungcan.2004.01.025, 15301872.
35. Mujoomdar A, Austin JHM, Malhotra R, Powell CA, Pearson GDN, Shiau MC, Raftopoulos H. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology 2007, 242:882-888. 10.1148/radiol.2423051707, 17229875.
36. Figlin RA, PiAanta D. Intracranial recurrence of carcinoma after complete surgical resection of stage I, II and III non-small-cell lung cancer. N Engl J Med 1988, 318:1300-1305. 10.1056/NEJM198805193182004, 2834646.
37. Keith B, Vincent M, Stitt L, Tomiak A, Malthaner R, Yu E, Truong P, Inculet R, Lefcoe M, Dar AR. Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small-cell lung cancer. Am J Clin Oncol 2002, 25:583-587. 10.1097/00000421-200212000-00011, 12478004.
38. Tang SGJ, Tseng CK, Tsay PK, Chen CH, Chang JWC, Pai PC, Hong JH. Predictors for patterns of brain relapse and overall survival in patients with non-small cell lung cancer. J Neurooncol 2005, 73:153-161. 10.1007/s11060-004-3725-4, 15981106.
39. Hubbs JL, Boyd JA, Hollis D, Chino JP, Saynak M, Kelsey CR. Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer. Cancer 2010, 116:5038-5046. 10.1002/cncr.25254, 20629035.
40. Matsuguma H, Oki I, Nakahara R, Ohata N, Igarashi S, Mori K, Endo S, Yokoi K. Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes. Eur J Cardiothorac Surg 2011, 41:19-24.
41. Jonnalagadda S, Arcinega J, Smith C, Wisnivesky JP. Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer. Cancer 2011, 117:4724-4731.